» Articles » PMID: 36093544

Extracranial Metastasis of Glioblastoma with Genomic Analysis: a Case Report and Review of the Literature

Overview
Specialty Oncology
Date 2022 Sep 12
PMID 36093544
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Glioblastoma (GBM) is the first most frequent type of primary malignant brain tumors in adults. It is basically confined to the brain, and extracranial metastases (ECM) are rare. The genomic features of GBM with ECM are not fully elucidated.

Case Description: Here, we present a case of a male patient with headache and left eye vision loss for 2 months who had a left occipital lobe tumor. GBM of grade IV [isocitrate dehydrogenase 1 (IDH-1) wild type] was diagnosed based on the histological profiles of intracranial tumor according to the World Health Organization standard. ECM of GBM located in the mediastinal lymph node occurred 6 months after resection of the intracranial tumor. High throughput gene sequencing was performed using ECM lesions. Mutated genes included tumor protein 53 (), CUB and Sushi multiple domains 3 (), poly(ADP-ribose) polymerase family member 4 (), and . The patient underwent surgery, radiotherapy, chemotherapy, and anti-angiogenic drug treatment. Unfortunately, the patient died 8 months after surgery.

Conclusions: ECM of GBM is rare, and its prognosis is very poor. Mutated genes in ECM included and in our case. Genomic analysis provides important insights into GBM and its ECM.

Citing Articles

Breaking boundaries: A rare case of glioblastoma with uncommon extraneural metastases: A case report and literature review.

Taule E, Brekke J, Miletic H, Saetran H, Maric S, HogenEsch I Brain Spine. 2025; 4():103927.

PMID: 39823071 PMC: 11736052. DOI: 10.1016/j.bas.2024.103927.


Metastatic glioblastoma to the lungs: a case report and literature review.

Yuen C, Pekmezci M, Bao S, Kong X CNS Oncol. 2024; 13(1):2351789.

PMID: 38864820 PMC: 11172249. DOI: 10.1080/20450907.2024.2351789.


Case report: Fulminant extraneural metastasis of glioblastoma through venous sinus.

Kim Y, Ahn K, Lee K, Moon K Front Oncol. 2022; 12:1034944.

PMID: 36338688 PMC: 9633940. DOI: 10.3389/fonc.2022.1034944.


Glioblastoma: an organ-confined disease?.

Cabezas-Camarero S, Perez-Alfayate R, Sotelo M Transl Cancer Res. 2022; 11(8):2473-2476.

PMID: 36093531 PMC: 9459603. DOI: 10.21037/tcr-22-1943.

References
1.
Lun M, Lok E, Gautam S, Wu E, Wong E . The natural history of extracranial metastasis from glioblastoma multiforme. J Neurooncol. 2011; 105(2):261-73. DOI: 10.1007/s11060-011-0575-8. View

2.
Atkins M, Larkin J . Immunotherapy Combined or Sequenced With Targeted Therapy in the Treatment of Solid Tumors: Current Perspectives. J Natl Cancer Inst. 2016; 108(6):djv414. DOI: 10.1093/jnci/djv414. View

3.
Rong T, Zou W, Qiu X, Cui W, Zhang D, Wu B . A Rare Manifestation of a Presumed Non-Osteophilic Brain Neoplasm: Extensive Axial Skeletal Metastases From Glioblastoma With Primitive Neuronal Components. Front Oncol. 2021; 11:760697. PMC: 8593252. DOI: 10.3389/fonc.2021.760697. View

4.
Bouffet E, Larouche V, Campbell B, Merico D, De Borja R, Aronson M . Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency. J Clin Oncol. 2016; 34(19):2206-11. DOI: 10.1200/JCO.2016.66.6552. View

5.
Amitendu S, Mak S, Ling J, Ng W . A single institution experience of the incidence of extracranial metastasis in glioma. J Clin Neurosci. 2012; 19(11):1511-5. DOI: 10.1016/j.jocn.2011.08.040. View